Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Belmora is a consumer healthcare company that specializes in the marketing and distribution of over-the-counter (OTC) medications, primarily targeting the Hispanic market in the United States. The company's flagship product is Flanax, a pain reliever containing naproxen sodium, which is a well-known brand in Mexico. Belmora focuses on bridging the gap for consumers who are familiar with international brands by making them available in U.S. retail channels. The company has been involved in significant trademark litigation regarding the use of the Flanax name in the U.S. against Bayer. Beyond pain relief, Belmora's portfolio includes various other OTC products designed to meet the needs of its target demographic. The company operates as a private entity based in Arlington, Virginia.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Belmora.